Axovant Sciences just topped our list of the 10 top penny stocks to watch this week thanks to its 150% gain.
Fortunately, we've found a way to find stocks with even bigger profit potential.
Last Thursday (June 7), shares of Axovant jumped 44% on news that the company will license its experimental treatment for Parkinson's disease.
Axovant finished the week at $4.81, a gain of 150% on Monday's share price.